Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
Gross Profit
Beijing Hotgen Biotech Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Gross Profit
¥331.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Gross Profit
¥15.8B
|
CAGR 3-Years
31%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Gross Profit
¥3.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Gross Profit
¥6.8B
|
CAGR 3-Years
39%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Gross Profit
¥2.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
21%
|
CAGR 10-Years
32%
|
|
Genscript Biotech Corp
HKEX:1548
|
Gross Profit
$409.6m
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Gross Profit?
Gross Profit
331.4m
CNY
Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Gross Profit amounts to 331.4m CNY.
What is Beijing Hotgen Biotech Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
19%
Over the last year, the Gross Profit growth was -81%. The average annual Gross Profit growth rates for Beijing Hotgen Biotech Co Ltd have been 1% over the past three years , 19% over the past five years .